Inoviv

Inoviv is a pioneer in precision medicine and spatial proteomics, developing highly quantitative, mass spectrometry-based proteomic assays to track disease biomarkers and drug response. Catering to pharmaceutical clinical trials, Inoviv’s targeted multiplex panels deliver reproducible, absolute quantification data that accelerates patient stratification and targeted therapeutic validation.